Newborn screening for Metachromatic leukodystrophy (MLD)

Reading time less than 1 minute Publication type:

Ongoing Projects

SBU assess relevant and well-conducted research and investigate what effect different interventions have, if there are any risks or ethical problems, and what is most cost-effective in the areas of health care, dentistry, social services, and within the areas of functional disability and work environment.

Contact SBU
Planned to be published: Quarter 1, 2025

MLD is under consideration for the newborn screening program and SBU will investigate part of the criteria that’s needed for the decision. The results will be delivered to the Swedish National Board of Health and Welfare.

 

MLD is an genetic inherited disease that affects the white matter and is divided into 4 kinds.

Page updated
To top